-
1
-
-
0020565187
-
Sulindac for polyposis of the colon
-
Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983; 24: 83-87
-
(1983)
J Surg Oncol
, vol.24
, pp. 83-87
-
-
Waddell, W.R.1
Loughry, R.W.2
-
2
-
-
0026316148
-
Eff ects of long-term sulindac therapy on colonic polyposis
-
Rigau J, Pique JM, Rubio E et al. Eff ects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 1991; 115: 952-954
-
(1991)
Ann Intern Med
, vol.115
, pp. 952-954
-
-
Rigau, J.1
Pique, J.M.2
Rubio, E.3
-
3
-
-
0025834849
-
Sulindac causes regression of rectal polyps in familial adenomatous polyposis
-
LaBayle D, Fischer D, Vielh P et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635-639
-
(1991)
Gastroenterology
, vol.101
, pp. 635-639
-
-
Labayle, D.1
Fischer, D.2
Vielh, P.3
-
4
-
-
0027197062
-
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
-
Giardiello FM, Hamilton SR, Krush AJ et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-1316
-
(1993)
N Engl J Med
, vol.328
, pp. 1313-1316
-
-
Giardiello, F.M.1
Hamilton, S.R.2
Krush, A.J.3
-
5
-
-
17744418769
-
The eff ect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
-
Steinbach G, Lynch PM, Phillips RK et al. The eff ect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946-1952
-
(2000)
N Engl J Med
, vol.342
, pp. 1946-1952
-
-
Steinbach, G.1
Lynch, P.M.2
Phillips, R.K.3
-
6
-
-
0037018508
-
Primary chemoprevention of familial adenomatous polyposis with sulindac
-
Giardiello FM, Yang VW, Hylind LM et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 2002; 346: 1054-1059
-
(2002)
N Engl J Med
, vol.346
, pp. 1054-1059
-
-
Giardiello, F.M.1
Yang, V.W.2
Hylind, L.M.3
-
7
-
-
0142250380
-
A randomized, double-blind, placebocontrolled trial of the eff ects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients
-
Higuchi T, Iwama T, Yoshinaga K et al. A randomized, double-blind, placebocontrolled trial of the eff ects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients. Clin Cancer Res 2003; 9: 4756-4760
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4756-4760
-
-
Higuchi, T.1
Iwama, T.2
Yoshinaga, K.3
-
8
-
-
20144365496
-
Pfeff er MA et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
-
Solomon SD, McMurray JJV, Pfeff er MA et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005; 352: 1071-1080
-
(2005)
N Engl J Med
, vol.352
, pp. 1071-1080
-
-
Solomon, S.D.1
McMurray, J.J.V.2
-
9
-
-
19744380776
-
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
-
Bresalier RS, Sandler RS, Quan H et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352: 1092-1102
-
(2005)
N Engl J Med
, vol.352
, pp. 1092-1102
-
-
Bresalier, R.S.1
Sandler, R.S.2
Quan, H.3
-
10
-
-
33748196958
-
Celecoxib for the prevention of sporadic colorectal adenomas
-
Bertagnolli MM, Eagle CJ, Zauber AG et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006; 355: 873-884
-
(2006)
N Engl J Med
, vol.355
, pp. 873-884
-
-
Bertagnolli, M.M.1
Eagle, C.J.2
Zauber, A.G.3
-
11
-
-
33748180713
-
Celecoxib for the prevention of colorectal adenomatous polyps
-
Arber N, Eagle CJ, Spicak J et al. Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 2006; 355: 885-895
-
(2006)
N Engl J Med
, vol.355
, pp. 885-895
-
-
Arber, N.1
Eagle, C.J.2
Spicak, J.3
-
12
-
-
33845288081
-
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas
-
Baron JA, Sandler RS, Bresalier RS et al. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 2006; 131: 1674-1682
-
(2006)
Gastroenterology
, vol.131
, pp. 1674-1682
-
-
Baron, J.A.1
Sandler, R.S.2
Bresalier, R.S.3
-
13
-
-
0007585236
-
APC genotype, polyp number, and surgical options in familial adenomatous polyposis
-
Wu J, Paul P, McGannon E et al. APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1999; 229: 445-446
-
(1999)
Ann Surg
, vol.229
, pp. 445-446
-
-
Wu, J.1
Paul, P.2
McGannon, E.3
-
14
-
-
0028934397
-
Surgery for the teenager with familial adenomatous polyposis: Ileo-rectal anastomosis or restorative proctocolectomy?
-
Ziv Y, Church JM, Oakley JR et al. Surgery for the teenager with familial adenomatous polyposis: ileo-rectal anastomosis or restorative proctocolectomy? Int J Colorect Dis 1995; 10: 6-9.
-
(1995)
Int J Colorect Dis
, vol.10
, pp. 6-9
-
-
Ziv, Y.1
Church, J.M.2
Oakley, J.R.3
-
15
-
-
66149123253
-
Cytochrome P450 2C9 variants infl uence response to celecoxib for prevention of colorectal adenoma
-
Chan AT, Zauber AG, Hsu M et al. Cytochrome P450 2C9 variants infl uence response to celecoxib for prevention of colorectal adenoma. Gastroenterology 2009; 136: 2127-2136
-
(2009)
Gastroenterology
, vol.136
, pp. 2127-2136
-
-
Chan, A.T.1
Zauber, A.G.2
Hsu, M.3
|